摘要
目的探讨神经导航辅助下早期微创治疗高血压性壳核出血的安全性和疗效。方法对20例诊断为高血压性壳核出血患者,神经导航辅助下行经单孔穿刺血肿,吸除大部分血肿后,留置引流;并与同期18例常规开颅手术进行比较。结果导航治疗组平均住院时间为(14±6)d,出院时基本痊愈7例,显著进步8例,进步3例,无变化1例,死亡1例;常规开颅组平均住院时间为(38±31)d,出院时基本痊愈1例,显著进步2例,进步7例,无变化1例,死亡7例。结论神经导航辅助下早期微创治疗高血压性壳核出血,可以明显改善患者的预后。
Objective To investigate the safety and effectiveness of minimally invasive treatment of hypertensive putamen hemorrhage （HPH） guided by neuronavigation in early stage. Methods Twenty patients diagnosed as HPH were treated by minimally invasive method in early stage. Under the guidance of neuronavigation, the hematoma was aspirated through frontal burr-hole, and drainage tube was inserted into the cavity of hematoma. The results were compared with the data of patients with HPH treated by routine craniotomy in the same period. Results The mean time of hospitalization was （14±6） d in neuronavigation group and （38±31 ） d in routine craniotomy group. Good recovery, significant progress, improvement, no change and death were found in 7,8,3,1 and 1 cases, respectively in navigation group, and 1,2,7,1 and 7, respectively in routine craniotomy group. Conclusion The prognosis of patients with HPH could be significantly improved with minimally invasive treatment guided by neuronavigation in early stage.
出处
《上海交通大学学报（医学版）》
CAS
CSCD
北大核心
2006年第7期770-773,共4页
Journal of Shanghai Jiao tong University:Medical Science
基金
上海市浦东新区科技局课题基金(PKJ2001-38)资助项目
关键词
高血压性脑出血
壳核出血
神经导航
微创治疗
hypertensive cerebral hemotoma
putamen hemorrhage
neuronavigation
minimally invasive treatment
